Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Urol
    July 2017
  1. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    >> Share

  2. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    >> Share

  3. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    >> Share

    March 2017
  4. SHIMIZU F, Muto S, Taguri M, Ieda T, et al
    Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Int J Urol. 2017 Mar 9. doi: 10.1111/iju.13324.
    >> Share

    February 2017
  5. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    >> Share

    January 2017
  6. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13290.
    >> Share

  7. MATSUMURA N, Nakamura Y, Kohjimoto Y, Nishizawa S, et al
    Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
    Int J Urol. 2017 Jan 9. doi: 10.1111/iju.13274.
    >> Share

    December 2016
  8. ALEVIZOPOULOS A, Tyritzis S, Leotsakos I, Anastasopoulou I, et al
    Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Int J Urol. 2016 Dec 22. doi: 10.1111/iju.13271.
    >> Share

  9. BESIROGLU H
    Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
    >> Share

    November 2016
  10. REIS LO
    Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016;23:963.
    >> Share

    October 2016
  11. VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
    Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
    >> Share

  12. HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
    Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
    Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
    >> Share

    September 2016
  13. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016 Sep 7. doi: 10.1111/iju.13220.
    >> Share

  14. CONTRERAS-SANZ A, Roberts ME, Seiler R, Black PC, et al
    Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Int J Urol. 2016 Sep 6. doi: 10.1111/iju.13193.
    >> Share

    July 2016
  15. YUASA T
    Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 31. doi: 10.1111/iju.13178.
    >> Share

  16. NAKAI Y, Anai S, Tanaka N, Chihara Y, et al
    Insignificant role of bacillus Calmette-Guerin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13167.
    >> Share

  17. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13164.
    >> Share

  18. KUBOTA Y, Nakaigawa N
    Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
    Int J Urol. 2016 Jul 3. doi: 10.1111/iju.13141.
    >> Share

    May 2016
  19. FUJITA K, Matsuzaki K
    Response to Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 30. doi: 10.1111/iju.13132.
    >> Share

  20. INAMOTO T, Azuma H
    Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 6. doi: 10.1111/iju.13115.
    >> Share

    April 2016
  21. MATSUZAKI K, Fujita K, Ujike T, Uemura M, et al
    Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 Apr 8. doi: 10.1111/iju.13100.
    >> Share

  22. DAL MORO F, Zattoni F
    Lighting from the urethral cystoscope side: A novel technique to safely manage bowel division during intracorporeal robotic urinary diversion.
    Int J Urol. 2016;23:344-5.
    >> Share

  23. JINZAKI M, Kikuchi E, Akita H, Sugiura H, et al
    Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Int J Urol. 2016;23:284-98.
    >> Share

    March 2016
  24. GOLABEK T, Bukowczan J
    Editorial Comment to Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Int J Urol. 2016;23:240.
    >> Share

    February 2016
  25. WASHIO M
    Editorial Comment to Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Feb 18. doi: 10.1111/iju.13064.
    >> Share

    January 2016
  26. KRABBE LM, Lotan Y
    Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Jan 14. doi: 10.1111/iju.13052.
    >> Share

    December 2015
  27. YAGISAWA T, Okumi M, Omoto K, Sawada Y, et al
    Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer.
    Int J Urol. 2015 Dec 21. doi: 10.1111/iju.13034.
    >> Share

    October 2015
  28. BALL MW
    Editorial Comment to Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12964.
    >> Share

  29. RICHARDS KA, Ham S, Cohn JA, Steinberg GD, et al
    Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12959.
    >> Share

    August 2015
  30. OH JJ, Kang MY, Jo JK, Lee HM, et al
    Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
    Int J Urol. 2015 Aug 20. doi: 10.1111/iju.12901.
    >> Share

    June 2015
  31. KAUSHIK D, Frank I, Boorjian SA, Cheville JC, et al
    Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Int J Urol. 2015;22:549-54.
    >> Share

    May 2015
  32. GAUTHIER H, Culine S
    Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:495.
    >> Share

  33. MUTO S, Abe H, Noguchi T, Sugiura S, et al
    Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:490-4.
    >> Share

    April 2015
  34. KANG M, Lee S, Jeong SJ, Hong SK, et al
    Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.
    Int J Urol. 2015;22:389-93.
    >> Share

    February 2015
  35. AKITA H, Okamura T, Nakane A, Kobayashi T, et al
    Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy.
    Int J Urol. 2015;22:234-5.
    >> Share

  36. GINORI A, Barone A, Santopietro R, Barbanti G, et al
    Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:222-5.
    >> Share

  37. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:163-70.
    >> Share

  38. SHIGEHARA K, Namiki M
    Editorial comment to Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:225-6.
    >> Share

  39. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Response to editorial comments to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:172.
    >> Share

  40. GONDO T
    Editorial comment from Dr Gondo to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:171.
    >> Share

  41. TSUZUKI T
    Editorial comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:170-1.
    >> Share

    January 2015
  42. ROBINSON R
    Editorial Comment to Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:61.
    >> Share

  43. PFISTER C, Kerkeni W, Rigaud J, Le Gal S, et al
    Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:53-60.
    >> Share

    September 2014
  44. ZAHRAN MH
    Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892-3.
    >> Share

  45. EL-GAMAL OM
    Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892.
    >> Share

  46. ZAHRAN MH, El-Hefnawy AS, Zidan EM, El-Bilsha MA, et al
    Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:887-92.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016